We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTUS icon
2101
Metallus
MTUS
$888M
$876K ﹤0.01%
139,344
+10,224
+8% +$67.1K
RRD
2102
DELISTED
RR Donnelley & Sons Co.
RRD
$876K ﹤0.01%
232,404
+12,628
+6% +$30K
FFWM
2103
DELISTED
First Foundation Inc
FFWM
$873K ﹤0.01%
57,133
+3,380
+6% +$48.6K
RDUS
2104
DELISTED
Radius Recycling
RDUS
$873K ﹤0.01%
42,244
+3,459
+9% +$83.4K
RVI
2105
DELISTED
Retail Value Inc. Common Shares
RVI
$873K ﹤0.01%
256,672
+21,560
+9% +$72.8K
MGNX icon
2106
MacroGenics
MGNX
$255M
$871K ﹤0.01%
68,282
+4,006
+6% +$57.7K
NRC icon
2107
NRC Health Common Stock
NRC
$431M
$868K ﹤0.01%
15,029
+270
+2% +$16.7K
NVEE
2108
DELISTED
NV5 Global
NVEE
$867K ﹤0.01%
50,792
-120
-0.2% -$2.18K
RVNC
2109
DELISTED
Revance Therapeutics, Inc.
RVNC
$867K ﹤0.01%
66,654
+3,258
+5% +$39.9K
TCRT icon
2110
Alaunos Therapeutics
TCRT
$4.86M
$866K ﹤0.01%
1,349
-9
-0.7% -$7.14K
MERC icon
2111
Mercer International
MERC
$45.2M
$863K ﹤0.01%
68,793
+699
+1% +$8.83K
FLIC
2112
DELISTED
First of Long Island Corp
FLIC
$862K ﹤0.01%
37,892
+3,077
+9% +$67.7K
DHT icon
2113
DHT Holdings
DHT
$2.96B
$861K ﹤0.01%
140,079
+12,400
+10% +$71.3K
NIC icon
2114
Nicolet Bankshares
NIC
$3.64B
$861K ﹤0.01%
12,934
+1,098
+9% +$70.8K
MBWM icon
2115
Mercantile Bank Corp
MBWM
$1.06B
$859K ﹤0.01%
26,202
+2,042
+8% +$65.7K
EBF icon
2116
Ennis
EBF
$562M
$857K ﹤0.01%
42,413
+3,446
+9% +$69.8K
TVTX icon
2117
Travere Therapeutics
TVTX
$5.89B
$856K ﹤0.01%
73,825
+1,157
+2% +$19.1K
CISN
2118
DELISTED
Cision Ltd. Ordinary Share
CISN
$855K ﹤0.01%
111,228
-900
-0.8% -$7.75K
BV icon
2119
BrightView Holdings
BV
$1.02B
$852K ﹤0.01%
49,705
+4,268
+9% +$78.8K
AGX icon
2120
Argan
AGX
$8.28B
$850K ﹤0.01%
21,623
-15,391
-42% -$622K
SNR
2121
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$850K ﹤0.01%
127,255
+6,203
+5% +$41.1K
GLDD
2122
DELISTED
Great Lakes Dredge & Dock
GLDD
$848K ﹤0.01%
81,146
+461
+0.6% +$4.87K
QCRH icon
2123
QCR Holdings
QCRH
$1.71B
$848K ﹤0.01%
22,328
+1,889
+9% +$68.4K
TCDA
2124
DELISTED
Tricida, Inc. Common Stock
TCDA
$842K ﹤0.01%
27,287
-512
-2% -$17.2K
GPRO icon
2125
GoPro
GPRO
$126M
$832K ﹤0.01%
160,505
+1,342
+0.8% +$6.3K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.